The Global Triple Negative Breast Cancer Treatment Market is expected to reach at a CAGR of 8% during the forecast period 2022-2028. Triple-negative breast cancer is different from other invasive breast cancers, it grows and spreads faster, has fewer treatment options, and has a poor prognosis (outcome). TNBC is classified as an aggressive disease because […]
